Introduction {#sec1-0300060518762988}
============

Osteoarthritis (OA) is a joint disease with various manifestations including articular cartilage fibrosis, ulcers, pain, stiffness, and attrition. The etiology of OA is still largely unknown, but various studies have indicated that its occurrence is associated with age, obesity, joint injury, and genetic factors.^[@bibr1-0300060518762988][@bibr2-0300060518762988]--[@bibr3-0300060518762988]^

Human MutY homolog (MUTYH) is a unique DNA glycosylase that excises adenine bases that have mispaired with 8-oxo-G during DNA replication. Dysfunctional *MUTYH* variants may lead to G:C to A:T transversions in the genome.^[@bibr4-0300060518762988]^ Previous studies revealed that MUTYH inactivation caused by genetic polymorphisms plays a crucial role in cancer-associated inflammatory responses.^[@bibr5-0300060518762988],[@bibr6-0300060518762988]^

Calcium release-activated calcium channel protein 1 (ORAI1), located on the plasma membrane, is an essential component of store-operated calcium channels (SOCCs). The interaction between ORAI1 and stromal interaction molecular 1 regulates intracellular calcium ion homeostasis through activating SOCCs and mediating their calcium entry.^[@bibr7-0300060518762988],[@bibr8-0300060518762988]^ Additionally, the haplotypes of *ORAI1* single nucleotide polymorphisms (SNPs) rs12313273 and rs7135617 are associated with the risk of developing HLA-B27-positive ankylosing spondylitis (AS).^[@bibr9-0300060518762988]^ Kung et al. previously showed that *MUTYH* SNPs rs3219463 and rs3219476 were associated with susceptibility to rheumatoid arthritis (RA) in Taiwanese patients.^[@bibr10-0300060518762988]^ Based on these results, we speculated that polymorphisms of *MUTYH* and *ORAI1* might affect the risk of OA in the Chinese Han population, but little is known of this potential association. Therefore, we carried out a case--control study to examine the association between *MUTYH* and *ORAI1* polymorphisms and susceptibility to OA in the Chinese Han population. Specifically, we examined five tagged SNPs (tSNPs) of *ORAI1* (rs712853, rs12313273, rs6486795, rs12320939, and rs7135617) with minor allele frequencies (MAFs) \>10% from the HapMap Han database, and the *MUTYH* SNP rs3219463.

Materials and methods {#sec2-0300060518762988}
=====================

Subject selection {#sec3-0300060518762988}
-----------------

Patients with OA diagnosed at the General Hospital of Ningxia Medical University (Ningxia, China) from October 2013 to May 2016 were included in the study. Patients were diagnosed with OA according to published guidelines.^[@bibr11-0300060518762988]^ The severity of OA was assessed using the Kallgren--Lawrence grading system; other types of arthritis were excluded from the study. Age- and gender-matched healthy control subjects were also recruited. Informed consent was obtained from all subjects and the study was approved by the Ethical Committee of the General Hospital of Ningxia Medical University.

Genomic DNA extraction and MUTYH and ORAI1 genotyping {#sec4-0300060518762988}
-----------------------------------------------------

A total of 10 mL of venous blood was collected from each subject. Genomic DNA was extracted from 2 mL blood using the QIAamp DNA Blood Mini Kit (Qiagen, Valencia, CA, USA). *MUTYH* and *ORAI1* genotyping was performed by Sanger sequencing.^[@bibr12-0300060518762988]^ Sequencing primers were synthesized as previously described.^[@bibr10-0300060518762988],[@bibr12-0300060518762988]^

Quantitative determination of MUTYH in the serum {#sec5-0300060518762988}
------------------------------------------------

The remaining 8 mL of blood was used as a serum sample and diluted 200-fold in dilution buffer (5% skim milk, w/v). MUTYH levels were then quantified by enzyme-linked immunosorbent assay (ELISA) (USCN Life™ Science & Technology, Wuhan, China). Recombinant MUTYH protein (PeproTech Inc., Rocky Hill, NJ, USA) was used as the standard. The amount of MUTYH in the serum was determined according to the standard curve and dilution ratio.

Statistical analysis {#sec6-0300060518762988}
--------------------

IBM SPSS Statistics, version 20.0 (IBM Corp., Armonk, NY, USA) was used for statistical analysis. Statistical differences in genotypes and allelic frequencies between cases and controls were assessed using the chi-squared test. The association of each SNP with OA was assessed using multivariate logistic regression analysis. The linkage disequilibrium (LD) map of the five tSNPs in *ORAI1* was constructed using Haploview software (version 4.2; <http://www.broad.mit.edu/mpg/haploview>/). The odds ratios (ORs) of genetic loci were calculated from genotype and allele frequencies with a 95% confidence interval (CI). Results were considered statistically significant when *P* values were less than 0.05.

Results {#sec7-0300060518762988}
=======

Subject characteristics {#sec8-0300060518762988}
-----------------------

This study included a total of 350 patients with OA and 350 healthy controls. Subject characteristics are shown in [Table 1](#table1-0300060518762988){ref-type="table"}. There was no significant difference in basal characteristics between the patients and controls.

###### 

Basal characteristics of patients with osteoarthritis and controls.

![](10.1177_0300060518762988-table1)

  ---------------------------------------------------------------------------------------------------
  Characteristics               Patients with OA\   Healthy controls\   *t/χ^*2*^*value   *P* value
                                (n = 350)           (n = 350)                             
  ----------------------------- ------------------- ------------------- ----------------- -----------
  Age (years)                   63.80 ± 11.52       64.10 ± 12.24       0.334             0.739

  Gender: male, n (%)           50 (14.29%)         55 (15.71%)         0.280             0.597

  Course (years)                6.10 ± 2.14         --                                    

  Education: n (%)                                                      0.625             0.731

  Primary school or below       75 (21.43%)         71 (20.29%)                           

  Middle school                 212 (60.57%)        208 (59.43%)                          

  Graduate and above            63 (18.00%)         71 (20.29%)                           

  Obesity: n (%)                189 (54.00%)        191 (54.57%)        0.023             0.879

  Heavy physical labor: n (%)   98 (28.00%)         120 (34.29%)        3.224             0.073

  Smoking history: n (%)        91 (26.00%)         114 (32.57%)        3.649             0.056

  Drinking history: n (%)       134 (38.29%)        158 (45.14%)        3.384             0.066
  ---------------------------------------------------------------------------------------------------

Association between ORAI1 rs7135617, MUTYH rs3219463, and the susceptibility of OA {#sec9-0300060518762988}
----------------------------------------------------------------------------------

We selected five tSNPs of *ORAI1* (rs712853, rs12313273, rs6486795, rs12320939, and rs7135617) with MAFs \>10% from the HapMap Han database. Genotype and allele frequencies were consistent with the Hardy--Weinberg equilibrium (HWE). A comparison of the difference in genotype and allele frequencies of SNPs between patients and controls showed that individuals carrying the rs7135617 TT genotype had a significantly higher risk of developing OA than individuals with other genotypes (*OR* = 1.332, 95%CI = 1.069--1.661, *P* =0.01) ([Table 2](#table2-0300060518762988){ref-type="table"}).

###### 

Genotype and allele frequencies of *ORAI1* and *MUTYH* and the risk of OA.

![](10.1177_0300060518762988-table2)

  ------------------------------------------------------------------------------------------
  *ORAI1*      Genotype   Patients\   Healthy\    *OR* (95% *CI*)        *P*\    Adjusted\
                          with OA\    controls\                          value   *P* value
                          (n = 350)   (n = 350)                                  
  ------------ ---------- ----------- ----------- ---------------------- ------- -----------
  rs712853                                                                       

               CC         34          37          0.875 (0.507--1.509)   0.609   0.704

               CT         150         155         0.921 (0.665--1.275)   0.607   0.663

               TT         166         158         ref                            

  Allele                                                                         

               C          218         229         0.93 (0.738--1.172)    0.528   0.566

               T          482         471         ref                            

  rs12313273                                                                     

               CC         27          30          0.890 (0.490--1.614)   0.683   0.791

               CT         142         141         0.894 (0.487--1.640)   0.699   0.809

               TT         181         179         ref                            

  Allele                                                                         

               C          196         202         0.959 (0.755--1.218)   0.722   0.767

               T          504         498         ref                            

  rs6486795                                                                      

               CC         52          47          1.090 (0.670--1.775)   0.714   0.804

               CT         163         170         0.945 (0.676--1320)    0.729   0.791

               TT         135         133         ref                            

  Allele                                                                         

               C          267         264         1.018 (0.816--1.271)   0.869   0.912

               T          433         436         ref                            

  rs12320939                                                                     

               TT         85          82          1.003 (0.644--1.562)   0.990   1

               TG         173         179         0.935 (0.643--1.360)   0.713   0.782

               GG         92          89          ref                            

  Allele                                                                         

               T          344         342         1.011 (0.816--1.254)   0.915   0.957

               G          356         358         ref                            

  rs7135617                                                                      

               TT         79          54          1.728 (1.112--2.686)   0.010   0.014

               TG         144         146         1.165 (0.826--1.643)   0.364   0.411

               GG         127         150         ref                            

  Allele                                                                         

               T          302         254         1.332 (1.069--1.661)   0.009   0.010

               G          398         446         ref                            

  *MUTYH*                                                                        

  rs3219463                                                                      

               AA         51          45          1.792 (1.091--2.945)   0.014   0.020

               AG         194         139         2.207 (1.569--3.104)   0.000   0.000

               GG         105         166         ref                            

  Allele                                                                         

               A          297         230         1.506 (1.204--1.83)    0.000   0.000

               G          403         470         ref                            
  ------------------------------------------------------------------------------------------

ref, reference.

The genotype and allele frequency distribution of *MUTYH* SNP rs3219463 is shown in [Table 2](#table2-0300060518762988){ref-type="table"}. The frequencies were consistent with the HWE. Individuals with the rs3219463 GA or GG genotype had a significantly higher risk of developing OA than individuals with other genotypes (*OR* =1.506, 95%CI = 1.204--1.830, *P* = 0.000).

Haplotype analysis of ORAI1 SNPs in OA susceptibility {#sec10-0300060518762988}
-----------------------------------------------------

To further confirm the existence of a correlation between *ORAI1* haplotypes and OA, we constructed an LD map ([Figure 1](#fig1-0300060518762988){ref-type="fig"}) and estimated the differences of haplotype frequencies between OA patients and controls.

![Linkage disequilibrium map of five *ORAI1* tSNPs.](10.1177_0300060518762988-fig1){#fig1-0300060518762988}

As shown in [Table 3](#table3-0300060518762988){ref-type="table"}, the haplotype analysis revealed that there was no significant correlation in rs12313273/rs7135617 or rs7135617/rs6486795 pairwise allelic comparisons.

###### 

Haplotype frequency of the *ORAI1* gene in patients with OA and normal controls.

![](10.1177_0300060518762988-table3)

  ---------------------------------------------------------------------------------------
  Haplotype              Patients\      Healthy\       *OR* (95% *CI*)        *P* value
                         with OA\       controls\                             
                         (n=350)        (n=350)                               
  ---------------------- -------------- -------------- ---------------------- -----------
  rs12313273/rs7135617                                                        

   T/T                   147 (42.00%)   143 (40.86%)   1.093 (0.748--1.597)   0.698

   T/G                   106 (30.29%)   106 (30.29%)   1.063 (0.707--1.598)   0.834

   C/G                   95 (27.14%)    101 (28.86%)   ref                    

  rs7135617/rs6486795                                                         

   T/T                   144 (41.14%)   142 (40.57%)   1.006 (0.710--1.427)   0.971

   G/T                   69 (19.71%)    75 (21.43%)    0.913 (0.596--1.400)   0.661

   G/C                   132 (37.71%)   131 (37.43%)   ref                    
  ---------------------------------------------------------------------------------------

Haplotype frequencies \<1% were excluded. ref, reference.

MUTYH expression levels in the serum {#sec11-0300060518762988}
------------------------------------

Serum levels of MUTYH protein from 350 OA patients and 350 controls were detected by ELISA. The mean MUTYH level of OA patients was significantly higher than that of healthy controls ([Figure 2](#fig2-0300060518762988){ref-type="fig"}, *P* \< 0.005). Individuals carrying mutant rs3219463 (GA+GG) genotypes also had significantly higher serum MUTYH levels than those with the wild-type genotype (AA) ([Figure 2](#fig2-0300060518762988){ref-type="fig"}, *P* \< 0.05).

![MUTYH expression levels in the serum of OA patients and controls. *P* \< 0.05 represents statistical significance.](10.1177_0300060518762988-fig2){#fig2-0300060518762988}

Discussion {#sec12-0300060518762988}
==========

OA is a chronic disease that can lead to the total degeneration of articular cartilage structure and function. The development of OA may also result in changes to other soft tissue parts of the body.^[@bibr13-0300060518762988][@bibr14-0300060518762988]--[@bibr15-0300060518762988]^ The most common symptoms include joint pain, swelling, stiffness, and functional limitations.^[@bibr16-0300060518762988]^ OA can be induced by a number of predisposing causes, including both occupational and non-occupational factors. Coggon et al.^[@bibr17-0300060518762988]^ showed that individuals who kneeled or squatted for prolonged periods had a higher risk of developing knee OA, which was also associated with obesity.^[@bibr18-0300060518762988]^ Moreover, Valdes *et al.*^[@bibr19-0300060518762988]^ analyzed the genotypes of 36 SNPs in 17 candidate genes, and found that multiple genetic variants could predict the risk of knee OA. Thus, genetic factors appear to be critical for the development of OA.

OA is traditionally thought to be associated with degeneration and trauma. However, increasing evidence suggests that it is not a single disease caused by aging or biological stress, but rather the accumulation of multiple factors such as metabolic disorders and inflammatory senescence. Lipid metabolism and body fluids are also involved in the initiation and progression of disease. Because the systemic inflammatory response associated with RA is believed to play an important role in the development of AS, it appears that OA, RA, and AS may share common features regarding the inflammatory response, while the incidence of OA and RA may be related to calcium signaling. Moreover, *MUYTH a*nd *ORAI1* SNPs have been significantly associated with the risk of chronic RA.^[@bibr6-0300060518762988],[@bibr12-0300060518762988]^ However, few studies have investigated the role of *MUYTH* and *ORAI1* SNPs in the susceptibility to OA in the Chinese Han population.

Here, we performed a case--control association study of *MUTYH* SNP rs3219463 and five *ORAI1* tSNPs (rs712853, rs12313273, rs6486795, rs12320939, and rs7135617). Gender was previously shown to be one of the key factors affecting the risk of OA,^[@bibr20-0300060518762988]^ so the 350 controls were age- and gender-matched to the 350 OA patients.

Other than the association between *MUTYH* SNPs and RA risk, *MUTYH* was also chosen as a target gene in this study because of the reported correlation between its polymorphisms and cancer-linked inflammatory responses.^[@bibr21-0300060518762988],[@bibr22-0300060518762988]^ Indeed, tumor inflammatory responses including tumor necrosis factor-α and interleukin-1β are important factors during OA development.^[@bibr23-0300060518762988],[@bibr24-0300060518762988]^

The Yen group previously reported that only the *MUTYH* SNP rs3219463 was relevant to the development of RA, so we focused on the association between rs3219463 and OA. As shown in [Table 2](#table2-0300060518762988){ref-type="table"}, individuals with the rs3219463 G allele (GA or GG genotypes) had a higher risk of developing OA than those with other genotypes. We also found that individuals with GA or GG rs3219463 genotypes had higher serum MUTYH levels than wild-type individuals with the AA genotype. Although it is not obvious why MUTYH accumulates in the serum, we propose that this might reflect the intracellular function of MUTYH.^[@bibr25-0300060518762988]^ We believe that SNP rs3219463 affects the expression level of MUTYH, but more *in vitro* studies will be needed to confirm this hypothesis.

The ORAI1-mediated calcium signaling pathway is associated with a range of diseases. *ORAI1* mutations may lead to disruption of the store-operated Ca^2+^ influx and the suppression of immune responses.^[@bibr26-0300060518762988]^ A number of *ORAI1* SNPs have been reported to be associated with human disease, including the correlation of rs7135617 with AS,^[@bibr9-0300060518762988]^ while *ORAI1* polymorphisms were shown to influence calcium signal transduction by affecting protein splicing.^[@bibr27-0300060518762988]^ We found that individuals with the rs7135617 TT genotype had a higher risk of developing OA. This may be because rs7135617 polymorphisms affect calcium signal transduction, causing Ca^2+^ signaling abnormalities during OA development.^[@bibr28-0300060518762988]^ Wen *et al.*^[@bibr29-0300060518762988]^ revealed differences in the characteristics of Ca^2+^ signals in different layers of normal cartilage tissue, which are regulated by extracellular Ca^2+^ concentrations. Moreover, the Ca^2+^ signal in OA chondrocytes differs from that in normal cells. Therefore, abnormalities of OA cartilage tissue may be linked to Ca^2+^ signal abnormalities, which could reflect differences in the expression of genes such as *MUTYH* and *ORAI1*. In our study, *ORAl1* rs7135617 T allele carriers and *MUTYH* rs3219463 G allele carriers had abnormal cartilage tissue Ca^2+^ signal responses, which would likely result in the dysfunction of OA cartilage cell voltage-regulated calcium channels and calcium-release activated channels. Additionally, Berenbaum *et al.*^[@bibr30-0300060518762988]^ showed that inflammatory cytokines play an important role in the pathogenesis of OA.

Our study has a number of limitations. First, we were unable to collect clinical biochemical data from OA patients, such as ORAI1 expression levels, so we only focused on the association between SNPs and the risk of OA. Second, we did not perform an *in vitro* analysis of the mechanisms affecting OA-associated risk factors. Finally, the small sample size of this study meant that no distinction could be made among individuals of different nationalities in China. Therefore, further study is required to confirm whether these SNPs are affected by different ethnic groups or sites of OA.

In conclusion, *MUTYH* SNP rs3219463 and *ORAI1* SNP rs7135617 appear to be associated with susceptibility to OA in the Chinese Han population. The SNPs may affect protein expression and function, which in turn affect the Ca^2+^ signaling pathway, resulting in disease development.
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